{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:06:18Z","timestamp":1783688778017,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1053\/j.seminhematol.2019.11.006","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:50:35Z","timestamp":1573735835000},"page":"257-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Issues in the development of hemoglobin based oxygen carriers"],"prefix":"10.1053","volume":"56","author":[{"given":"Timothy N.","family":"Estep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2019.11.006_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/089419300272122","article-title":"Hemoglobin solutions as blood substitutes","volume":"13","author":"Friedman","year":"2000","journal-title":"J Invest Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0002","first-page":"211","article-title":"Toxicity of polymerized hemoglobin solutions","volume":"166","author":"Feola","year":"1988","journal-title":"Surg Gynecol Obstet"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1537-2995.2003.00314.x","article-title":"Hb-based oxygen carriers: are we there yet?","volume":"43","author":"Reid","year":"2003","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0004","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/00003246-200006000-00034","article-title":"Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis","volume":"28","author":"Habler","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.shk.0000226338.48033.c2","article-title":"Bovine polymerized hemoglobin versus Hextend resuscitation in a swine model of severe controlled hemorrhagic shock with delay to definitive care","volume":"26","author":"Rice","year":"2006","journal-title":"Shock"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0006","first-page":"553","article-title":"Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury","volume":"59","author":"King","year":"2005","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0007","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3565(24)29531-8","article-title":"Effects of diaspirin cross-linked hemoglobin (DCLHb) during and post-CPR in swine","volume":"297","author":"Chow","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0008","doi-asserted-by":"crossref","first-page":"H1126","DOI":"10.1152\/ajpheart.00076.2006","article-title":"A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia","volume":"291","author":"George","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0317167100047363","article-title":"Focal cerebral ischemia in rats: effect of hemodilution with \u03b1-\u03b1 cross-linked hemoglobin on brain injury and edema","volume":"20","author":"Cole","year":"1993","journal-title":"Can J Neurol Sci"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0010","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/01.STR.25.11.2253","article-title":"Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits","volume":"25","author":"Bowes","year":"1994","journal-title":"Stroke"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0039-6060(97)90311-1","article-title":"Bovine hemoglobin increases skeletal muscule oxygenation during 95% artificial arterial stenosis","volume":"121","author":"Horn","year":"1997","journal-title":"Surgery"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0012","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cvr\/28.8.1188","article-title":"Effects of diaspirin crosslinked haemoglobin during coronary angioplasty in the swine","volume":"28","author":"McKenzie","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.anes.0000271872.14311.b4","article-title":"The novel hemoglobin-based oxygen carrier HRC 101 improves survival in murine sickle cell disease","volume":"107","author":"Crawford","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0014","first-page":"301","article-title":"PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy","volume":"11","author":"Teicher","year":"1997","journal-title":"In Vivo"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0015","first-page":"167","article-title":"Increased tissue oxygenation and enhanced radiation sensitivity of solid tumors in rodents following polyethylene glycol conjugated bovine hemoglobin administration","volume":"12","author":"Linberg","year":"1998","journal-title":"In Vivo"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0016","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0016-5085(91)90087-2","article-title":"Effectiveness of a purified human hemoglobin as a blood substitute in the perfused rat liver","volume":"101","author":"Starnes","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0017","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00002480-200009000-00007","article-title":"Cardiac function after eight hour storage by using polyethylene glycol hemoglobin versus crystalloid perfusion","volume":"46","author":"Serna","year":"2000","journal-title":"ASAIO J"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0018","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5223(19)35530-8","article-title":"Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement","volume":"100","author":"Vlahakes","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199004000-00003","article-title":"The efficacy of polymerized pyrodoxylated hemoglobin solution as an O2 carrier","volume":"211","author":"Gould","year":"1990","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00003246-200104000-00030","article-title":"Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit","volume":"29","author":"Meisner","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1213\/01.ANE.0000068888.02977.DA","article-title":"Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial","volume":"97","author":"Schubert","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0022","first-page":"1484","article-title":"HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter Phase III trial in elective orthopedic surgery","volume":"64","author":"Jahr","year":"2008","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0023","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM200006013422204","article-title":"Transfusions of polymerized bovine hemoglobin in a patient with severe autoimune hemolytic anemia","volume":"342","author":"Mullon","year":"2000","journal-title":"New Eng J Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0024","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5694\/j.1326-5377.2011.tb03064.x","article-title":"A synthetic haemoglobin-based oxygen carrier and the reversal of cardiac hypoxia secondary to severe anaemia following trauma","volume":"194","author":"Fitzgerald","year":"2011","journal-title":"Med J Aust"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcrc.2018.04.008","article-title":"Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: a case report","volume":"51","author":"Marrazzo","year":"2019","journal-title":"J Crit Care. Epub"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0026","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.299.19.jrv80007","article-title":"Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death","volume":"299","author":"Natanson","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/trf.14435","article-title":"Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016","volume":"58","author":"Vostal","year":"2018","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0028","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.CCM.0000217920.48559.D8","article-title":"Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting","volume":"34","author":"Koch","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0029","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jvs.2014.10.106","article-title":"The association of perioperative transfusion with 30-day morbidity and mortalitiy in patients undergoing major vascular surgery","volume":"61","author":"Obi","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0030","doi-asserted-by":"crossref","first-page":"h3037","DOI":"10.1136\/bmj.h3037","article-title":"Harms associated with single unit perioperative transfusion: retrospective population based analysis","volume":"350","author":"Whitlock","year":"2015","journal-title":"BMJ"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.avsg.2017.06.154","article-title":"Variation in transfusion practices and the association with perioperative adverse events in patients undergoing open abdominal aortic aneurysm repair and lower extremity arterial bypass in the vascular quality initiative","volume":"46","author":"Osborne","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0032","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMoa070403","article-title":"Duration of red-cell storage and complications after cardiac surgery","volume":"358","author":"Koch","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2019.11.006_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2011.03466.x","article-title":"Transfusion of older stored blood and risks of death: a meta-analysis","volume":"52","author":"Wang","year":"2012","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0034","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI59770","article-title":"Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy","volume":"122","author":"Baek","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10731199709118911","article-title":"Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions","volume":"25","author":"Simoni","year":"1997","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0036","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.282.19.1857","article-title":"Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock","volume":"282","author":"Sloan","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0037","first-page":"887","article-title":"Post Hoc Mortality Analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock","volume":"52","author":"Sloan","year":"2002","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0038","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1152\/jappl.2002.92.1.343","article-title":"Comparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep","volume":"92","author":"Vane","year":"2002","journal-title":"J Appl Physiol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0039","first-page":"H2194","article-title":"Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep","volume":"276","author":"Fischer","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0741-5214(00)90161-7","article-title":"The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution","volume":"31","author":"LaMuraglia","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0041","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00134-002-1622-x","article-title":"DCH-Hb for trauma patients with severe a shock: the European \u201cOn-Scene\u201d multicenter study","volume":"29","author":"Kerner","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0042","unstructured":"Northfield laboratories releases summary observations from its elective surgery trial [news release] (2006). Evanston, IL: Northfield Laboratories Inc. Available from from http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=91374&p=irol-newsArticle_print&ID=833808&highlight=. [accessed 16 December 2017]."},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/SHK.0b013e3181ac482b","article-title":"DCLHb Traumatic Hemorrhagic Shock Study Group; European HOST Investigators. The lack of consistent diaspirin cross-linked hemoglobin infusion blood pressure effects in the US and EU traumatic hemorrhagic shock clinical trials","volume":"33","author":"Sloan","year":"2010","journal-title":"Shock"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0044","first-page":"1158","article-title":"DCLHb Traumatic Hemorrhagic Shock Study Group; European HOST Investigators","volume":"68","author":"Sloan","year":"2010","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2008.09.023","article-title":"PolyHeme Study Group. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable; the USA multicenter trial","volume":"208","author":"Moore","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/21691401.2019.1573181","article-title":"Haemoglobin-based oxygen carriers and myocardial infarction","volume":"47","author":"Estep","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0047","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.freeradbiomed.2003.11.030","article-title":"NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes","volume":"36","author":"Olson","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0048","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/10731199409117888","article-title":"Regional circulatory and systemic hemodynamic effects of diaspirin cross-linked hemoglobin in the rat. Artif Cells","volume":"22","author":"Sharma","year":"1994","journal-title":"Blood Substit Immobil Biotechnol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0049","first-page":"51","article-title":"Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine","volume":"67","author":"Mongan","year":"2009","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4244\/EIJV4I1A17","article-title":"Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design and haemodynamic results","volume":"4","author":"Meliga","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0051","doi-asserted-by":"crossref","first-page":"H908","DOI":"10.1152\/ajpheart.2000.279.3.H908","article-title":"Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension","volume":"279","author":"Sakai","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0052","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/157016312802650733","article-title":"Adverse HBOC-endothelial dysfunction synergism: a possible contributor to adverse clinical outcomes","volume":"9","author":"Biro","year":"2012","journal-title":"Curr Drug Discov Technol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0053","series-title":"Hemoglobin-based oxygen carriers as red cell substitutes and oxygen therapeutics","first-page":"665","article-title":"Redox activity of cell-free hemoglobin: implications for vascular oxidative stress and endothelial dysfunction","author":"D'Agnillo","year":"2013"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0054","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/clinchem\/43.9.1732","article-title":"Effect of hemoglobin- and perflubron-based oxygen carriers on common clinical laboratory tests","volume":"43","author":"Ma","year":"1997","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0055","first-page":"505","article-title":"A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol","volume":"90","author":"Bj\u00f6rkholom","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0056","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clinbiochem.2008.10.023","article-title":"Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier","volume":"42","author":"Cameron","year":"2009","journal-title":"Hemospan. Clin Biochem."},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0057","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1258\/000456306775141687","article-title":"Mechanism of interference by haemolysis in the cardiac troponin T immunoassay","volume":"43","author":"Sodi","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0058","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1373\/clinchem.2003.026591","article-title":"Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: Confirmation by size-exclusion HPLC","volume":"50","author":"Varlet-Marie","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0059","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/ajcp\/112.6.745","article-title":"Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay","volume":"112","author":"ver Elst","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jcla.5","article-title":"Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK-MB assay","volume":"15","author":"Dasgupta","year":"2001","journal-title":"J Clin Lab Anal"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0061","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/trf.13676","article-title":"Trends in United States blood collection and transfusion: results from the 2013 AABB blood collection, utilization, and patient blood management survey","volume":"56","author":"Whitaker","year":"2016","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0062","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.1109736108","article-title":"Large-scale production of functional human serum albumin from transgenic rice seeds","volume":"108","author":"He","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0063","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/157016312802650779","article-title":"Practical considerations in the development of hemoglobin-based oxygen therapeutics","volume":"9","author":"Kim","year":"2012","journal-title":"Curr Drug Discov Technol"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0064","series-title":"Hemoglobin-based oxygen carriers as red cell substitutes and oxygen therapeutics","first-page":"3","article-title":"From hemoglobin based oxygen carrier to oxygen therapeutics, blood substitutes, nanomedicine and artificial cells","author":"Chang","year":"2013"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0065","series-title":"Red blood cell substitutes basic principles and clinical applications","first-page":"309","article-title":"Human hemoglobin derived from transgenic swine: a starting material for \u201cblood substitute\u201d formulations","author":"Kumar","year":"1998"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0066","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1089\/ars.2012.4917","article-title":"Development of recombinant hemoglobin-based oxygen carriers","volume":"18","author":"Varnado","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0067","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/trf.12339","article-title":"Balancing risks and benefits of hemoglobin-based oxygen carriers","volume":"53","author":"Weiskopf","year":"2013","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0068","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4244\/EIJV4I1A26","article-title":"HBOC-201: the multi-purpose oxygen therapeutic","volume":"4","author":"Dub\u00e9","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0069","series-title":"Blood substitutes and oxygen carriers","first-page":"241","article-title":"Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies","author":"Nelson","year":"1993"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-3148.2010.01016.x","article-title":"Serial oxygen equilibrium and kinetic measurements during RBC storage","volume":"20","author":"Gelderman","year":"2010","journal-title":"Transfus Med"},{"key":"10.1053\/j.seminhematol.2019.11.006_bib0071","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1537-2995.2008.01734.x","article-title":"Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods","volume":"48","author":"Luten","year":"2008","journal-title":"Transfusion"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631930068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631930068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:26:14Z","timestamp":1758522374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719631930068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S003719631930068X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2019.11.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Issues in the development of hemoglobin based oxygen carriers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2019.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}